ince bio power limited
ince bio power limited Company Information
Company Number
09386360
Next Accounts
Sep 2025
Shareholders
stanlow bio power limited
Group Structure
View All
Industry
Other professional, scientific and technical activities (not including environmental consultancy or quantity surveying) n.e.c.
Registered Address
c/o evero energy group limited, 28 austin friars, london, EC2N 2QQ
Website
-ince bio power limited Estimated Valuation
Pomanda estimates the enterprise value of INCE BIO POWER LIMITED at £21.5m based on a Turnover of £23.7m and 0.91x industry multiple (adjusted for size and gross margin).
ince bio power limited Estimated Valuation
Pomanda estimates the enterprise value of INCE BIO POWER LIMITED at £0 based on an EBITDA of £-41k and a 6.06x industry multiple (adjusted for size and gross margin).
ince bio power limited Estimated Valuation
Pomanda estimates the enterprise value of INCE BIO POWER LIMITED at £0 based on Net Assets of £-174.4m and 2.35x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Ince Bio Power Limited Overview
Ince Bio Power Limited is a live company located in london, EC2N 2QQ with a Companies House number of 09386360. It operates in the other professional, scientific and technical activities n.e.c. sector, SIC Code 74909. Founded in January 2015, it's largest shareholder is stanlow bio power limited with a 100% stake. Ince Bio Power Limited is a established, large sized company, Pomanda has estimated its turnover at £23.7m with rapid growth in recent years.
Upgrade for unlimited company reports & a free credit check
Ince Bio Power Limited Health Check
Pomanda's financial health check has awarded Ince Bio Power Limited a 3.5 rating. We use a traffic light system to show it exceeds the industry average on 4 measures and has 6 areas for improvement. Company Health Check FAQs
4 Strong
2 Regular
6 Weak
Size
annual sales of £23.7m, make it larger than the average company (£2.9m)
£23.7m - Ince Bio Power Limited
£2.9m - Industry AVG
Growth
3 year (CAGR) sales growth of 35%, show it is growing at a faster rate (7.2%)
35% - Ince Bio Power Limited
7.2% - Industry AVG
Production
with a gross margin of 37.5%, this company has a comparable cost of product (44.9%)
37.5% - Ince Bio Power Limited
44.9% - Industry AVG
Profitability
an operating margin of -17.9% make it less profitable than the average company (5.6%)
-17.9% - Ince Bio Power Limited
5.6% - Industry AVG
Employees
with 3 employees, this is below the industry average (23)
3 - Ince Bio Power Limited
23 - Industry AVG
Pay Structure
on an average salary of £75.3k, the company has a higher pay structure (£53.6k)
£75.3k - Ince Bio Power Limited
£53.6k - Industry AVG
Efficiency
resulting in sales per employee of £7.9m, this is more efficient (£126.3k)
£7.9m - Ince Bio Power Limited
£126.3k - Industry AVG
Debtor Days
it gets paid by customers after 54 days, this is near the average (56 days)
54 days - Ince Bio Power Limited
56 days - Industry AVG
Creditor Days
its suppliers are paid after 15 days, this is quicker than average (31 days)
15 days - Ince Bio Power Limited
31 days - Industry AVG
Stock Days
it holds stock equivalent to 21 days, this is less than average (30 days)
21 days - Ince Bio Power Limited
30 days - Industry AVG
Cash Balance
has cash to cover current liabilities for 12 weeks, this is less cash available to meet short term requirements (25 weeks)
12 weeks - Ince Bio Power Limited
25 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 249%, this is a higher level of debt than the average (53.3%)
249% - Ince Bio Power Limited
53.3% - Industry AVG
INCE BIO POWER LIMITED financials
Ince Bio Power Limited's latest turnover from December 2023 is £23.7 million and the company has net assets of -£174.4 million. According to their latest financial statements, Ince Bio Power Limited has 3 employees and maintains cash reserves of £4.8 million as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | |
|---|---|---|---|---|---|---|---|---|---|
| Turnover | 23,702,000 | 27,919,000 | 14,285,000 | 9,549,000 | 7,816,000 | 2,249,000 | |||
| Other Income Or Grants | |||||||||
| Cost Of Sales | 14,814,000 | 13,244,000 | 11,412,000 | 9,260,000 | 6,157,000 | 2,249,000 | |||
| Gross Profit | 8,888,000 | 14,675,000 | 2,873,000 | 289,000 | 1,659,000 | ||||
| Admin Expenses | 13,143,000 | -9,500,000 | 15,422,000 | 20,669,000 | 8,089,000 | -3,162,000 | 2,895,000 | ||
| Operating Profit | -4,255,000 | 24,175,000 | -12,549,000 | -20,380,000 | -6,430,000 | 3,162,000 | -2,895,000 | -7,158,865 | -323,873 |
| Interest Payable | 47,445,000 | 43,117,000 | 23,319,000 | 16,058,000 | 15,555,000 | 93,793 | 729,739 | ||
| Interest Receivable | 2,426 | ||||||||
| Pre-Tax Profit | -51,700,000 | -18,942,000 | -35,868,000 | -36,438,000 | -21,985,000 | 3,228,000 | -2,993,000 | -7,252,658 | -38,638 |
| Tax | -2,774,000 | 6,746,000 | 5,475,000 | 1,833,000 | |||||
| Profit After Tax | -51,700,000 | -21,716,000 | -29,122,000 | -30,963,000 | -20,152,000 | 3,228,000 | -2,993,000 | -7,252,658 | -38,638 |
| Dividends Paid | |||||||||
| Retained Profit | -51,700,000 | -21,716,000 | -29,122,000 | -30,963,000 | -20,152,000 | 3,228,000 | -2,993,000 | -7,252,658 | -38,638 |
| Employee Costs | 226,000 | 205,000 | 186,000 | 189,000 | 50,000 | 54,000 | 52,052 | 12,695 | |
| Number Of Employees | 3 | 5 | 5 | 5 | 5 | 4 | 5 | 5 | |
| EBITDA* | -41,000 | 28,709,000 | -8,417,000 | -15,705,000 | -1,796,000 | 3,162,000 | -2,895,000 | -7,158,865 | -323,873 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | |
|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 101,144,000 | 105,123,000 | 88,171,000 | 97,378,000 | 112,885,000 | 111,311,000 | 93,902,000 | 72,077,334 | 38,860,274 |
| Intangible Assets | |||||||||
| Investments & Other | 14,054,000 | 7,308,000 | |||||||
| Debtors (Due After 1 year) | |||||||||
| Total Fixed Assets | 101,144,000 | 105,123,000 | 102,225,000 | 104,686,000 | 112,885,000 | 111,311,000 | 93,902,000 | 72,077,334 | 38,860,274 |
| Stock & work in progress | 887,000 | 827,000 | 721,000 | 997,000 | |||||
| Trade Debtors | 3,549,000 | 1,633,000 | 2,870,000 | 1,628,000 | 1,743,000 | 6,537,000 | 162,000 | 40,333 | |
| Group Debtors | |||||||||
| Misc Debtors | 6,661,000 | 2,815,000 | 5,981,000 | 5,703,000 | 7,032,000 | 557,000 | 625,000 | 1,450,889 | 5,374,751 |
| Cash | 4,828,000 | 4,954,000 | 667,000 | 988,000 | 1,058,000 | 1,682,000 | 1,500,000 | 1,650,606 | 3,100,054 |
| misc current assets | |||||||||
| total current assets | 15,925,000 | 10,229,000 | 10,239,000 | 9,316,000 | 9,833,000 | 8,776,000 | 2,287,000 | 3,141,828 | 8,474,805 |
| total assets | 117,069,000 | 115,352,000 | 112,464,000 | 114,002,000 | 122,718,000 | 120,087,000 | 96,189,000 | 75,219,162 | 47,335,079 |
| Bank overdraft | |||||||||
| Bank loan | |||||||||
| Trade Creditors | 632,000 | 1,037,000 | 2,470,000 | 3,726,000 | 791,000 | 814,000 | 100,000 | 44,592 | 837,216 |
| Group/Directors Accounts | 4,184,000 | 923,000 | 432,000 | ||||||
| other short term finances | 6,814,000 | 9,667,000 | 6,885,000 | 3,662,000 | 3,663,000 | ||||
| hp & lease commitments | |||||||||
| other current liabilities | 7,712,000 | 4,936,000 | 4,226,000 | 4,256,000 | 2,701,000 | 4,536,000 | 726,000 | 3,259,214 | 12,116,835 |
| total current liabilities | 19,342,000 | 16,563,000 | 14,013,000 | 11,644,000 | 7,155,000 | 5,350,000 | 826,000 | 3,303,806 | 12,954,051 |
| loans | 272,119,000 | 221,481,000 | 188,147,000 | 162,933,000 | 145,175,000 | 78,255,960 | 32,683,976 | ||
| hp & lease commitments | |||||||||
| Accruals and Deferred Income | |||||||||
| other liabilities | 124,197,000 | 108,051,000 | 3,354,390 | 1,735,680 | |||||
| provisions | |||||||||
| total long term liabilities | 272,119,000 | 221,481,000 | 188,147,000 | 162,933,000 | 145,175,000 | 124,197,000 | 108,051,000 | 81,610,350 | 34,419,656 |
| total liabilities | 291,461,000 | 238,044,000 | 202,160,000 | 174,577,000 | 152,330,000 | 129,547,000 | 108,877,000 | 84,914,156 | 47,373,707 |
| net assets | -174,392,000 | -122,692,000 | -89,696,000 | -60,575,000 | -29,612,000 | -9,460,000 | -12,688,000 | -9,694,994 | -38,628 |
| total shareholders funds | -174,392,000 | -122,692,000 | -89,696,000 | -60,575,000 | -29,612,000 | -9,460,000 | -12,688,000 | -9,694,994 | -38,628 |
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | |
|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||
| Operating Profit | -4,255,000 | 24,175,000 | -12,549,000 | -20,380,000 | -6,430,000 | 3,162,000 | -2,895,000 | -7,158,865 | -323,873 |
| Depreciation | 4,214,000 | 4,534,000 | 4,132,000 | 4,675,000 | 4,634,000 | ||||
| Amortisation | |||||||||
| Tax | -2,774,000 | 6,746,000 | 5,475,000 | 1,833,000 | |||||
| Stock | 60,000 | 106,000 | -276,000 | 997,000 | |||||
| Debtors | 5,762,000 | -4,403,000 | 1,520,000 | -1,444,000 | 1,681,000 | 6,307,000 | -704,222 | -3,883,529 | 5,374,751 |
| Creditors | -405,000 | -1,433,000 | -1,256,000 | 2,935,000 | -23,000 | 714,000 | 55,408 | -792,624 | 837,216 |
| Accruals and Deferred Income | 2,776,000 | 710,000 | -30,000 | 1,555,000 | -1,835,000 | 3,810,000 | -2,533,214 | -8,857,621 | 12,116,835 |
| Deferred Taxes & Provisions | |||||||||
| Cash flow from operations | -3,492,000 | 29,509,000 | -4,201,000 | -5,293,000 | -3,502,000 | 1,379,000 | -4,668,584 | -12,925,581 | 7,255,427 |
| Investing Activities | |||||||||
| capital expenditure | -35,620,768 | -29,040,136 | |||||||
| Change in Investments | -14,054,000 | 6,746,000 | 7,308,000 | ||||||
| cash flow from investments | -35,620,768 | -29,040,136 | |||||||
| Financing Activities | |||||||||
| Bank loans | |||||||||
| Group/Directors Accounts | 3,261,000 | 491,000 | 432,000 | ||||||
| Other Short Term Loans | -2,853,000 | 2,782,000 | 3,223,000 | -1,000 | 3,663,000 | ||||
| Long term loans | 50,638,000 | 33,334,000 | 25,214,000 | 17,758,000 | 145,175,000 | -78,255,960 | 45,571,984 | 32,683,976 | |
| Hire Purchase and Lease Commitments | |||||||||
| other long term liabilities | -124,197,000 | 16,146,000 | 104,696,610 | 1,618,710 | 1,735,680 | ||||
| share issue | |||||||||
| interest | -47,445,000 | -43,117,000 | -23,319,000 | -16,058,000 | -15,555,000 | -93,793 | -727,313 | ||
| cash flow from financing | 3,601,000 | -17,790,000 | 5,551,000 | 1,699,000 | 9,086,000 | 16,146,000 | 26,440,644 | 44,693,193 | 33,692,353 |
| cash and cash equivalents | |||||||||
| cash | -126,000 | 4,287,000 | -321,000 | -70,000 | -624,000 | 182,000 | -150,606 | -1,449,448 | 3,100,054 |
| overdraft | |||||||||
| change in cash | -126,000 | 4,287,000 | -321,000 | -70,000 | -624,000 | 182,000 | -150,606 | -1,449,448 | 3,100,054 |
ince bio power limited Credit Report and Business Information
Ince Bio Power Limited Competitor Analysis
Perform a competitor analysis for ince bio power limited by selecting its closest rivals, whether from the PROFESSIONAL, SCIENTIFIC AND TECHNICAL ACTIVITIES sector, other large companies, companies in EC2N area or any other competitors across 12 key performance metrics.
ince bio power limited Ownership
INCE BIO POWER LIMITED group structure
Ince Bio Power Limited has no subsidiary companies.
Ultimate parent company
2 parents
INCE BIO POWER LIMITED
09386360
ince bio power limited directors
Ince Bio Power Limited currently has 4 directors. The longest serving directors include Mr Mark Roberts (May 2019) and Mr Andrew Richardson (Sep 2019).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Mark Roberts | United Kingdom | 45 years | May 2019 | - | Director |
| Mr Andrew Richardson | England | 52 years | Sep 2019 | - | Director |
| Mrs Paige Matthews | United Kingdom | 34 years | Mar 2024 | - | Director |
| Mr Ian Jackson | United Kingdom | 62 years | Feb 2025 | - | Director |
P&L
December 2023turnover
23.7m
-15%
operating profit
-4.3m
-118%
gross margin
37.5%
-28.66%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2023net assets
-174.4m
+0.42%
total assets
117.1m
+0.01%
cash
4.8m
-0.03%
net assets
Total assets minus all liabilities
ince bio power limited company details
company number
09386360
Type
Private limited with Share Capital
industry
74909 - Other professional, scientific and technical activities (not including environmental consultancy or quantity surveying) n.e.c.
incorporation date
January 2015
age
10
incorporated
UK
ultimate parent company
accounts
Full Accounts
last accounts submitted
December 2023
previous names
N/A
accountant
-
auditor
BDO LLP
address
c/o evero energy group limited, 28 austin friars, london, EC2N 2QQ
Bank
-
Legal Advisor
-
ince bio power limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 3 charges/mortgages relating to ince bio power limited. Currently there are 3 open charges and 0 have been satisfied in the past.
ince bio power limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for INCE BIO POWER LIMITED. This can take several minutes, an email will notify you when this has completed.
ince bio power limited Companies House Filings - See Documents
| date | description | view/download |
|---|
